Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 678

1.

Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology.

Mohammed NN, Majumdar S, Singh A, Deng W, Murthy NS, Pinto E, Tewari D, Durig T, Repka MA.

AAPS PharmSciTech. 2012 Dec;13(4):1158-69. doi: 10.1208/s12249-012-9834-z.

2.

In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.

Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME.

Drug Dev Ind Pharm. 2013 Nov;39(11):1651-62. doi: 10.3109/03639045.2012.729146.

PMID:
23094867
3.

Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.

Agrawal A, Dudhedia M, Deng W, Shepard K, Zhong L, Povilaitis E, Zimny E.

AAPS PharmSciTech. 2016 Feb;17(1):214-32. doi: 10.1208/s12249-015-0472-0.

4.

In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator.

Pai R, Kohli K, Jain G, Srivastava B.

Arch Pharm Res. 2011 Jul;34(7):1135-42. doi: 10.1007/s12272-011-0711-1.

PMID:
21811920
5.

Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.

Xu M, Zhang C, Luo Y, Xu L, Tao X, Wang Y, He H, Tang X.

Drug Dev Ind Pharm. 2014 Jan;40(1):126-35. doi: 10.3109/03639045.2012.752497.

PMID:
23336809
6.

Role of cellulose ether polymers on ibuprofen release from matrix tablets.

Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME.

Drug Dev Ind Pharm. 2005 Aug;31(7):653-65.

PMID:
16207613
7.

A combined technique based on prilling and microwave assisted treatments for the production of ketoprofen controlled release dosage forms.

Auriemma G, Del Gaudio P, Barba AA, d'Amore M, Aquino RP.

Int J Pharm. 2011 Aug 30;415(1-2):196-205. doi: 10.1016/j.ijpharm.2011.05.077.

PMID:
21679754
8.

Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.

Tho I, Liepold B, Rosenberg J, Maegerlein M, Brandl M, Fricker G.

Eur J Pharm Sci. 2010 Apr 16;40(1):25-32. doi: 10.1016/j.ejps.2010.02.003.

PMID:
20172027
9.

Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion.

Deng W, Majumdar S, Singh A, Shah S, Mohammed NN, Jo S, Pinto E, Tewari D, Durig T, Repka MA.

Drug Dev Ind Pharm. 2013 Feb;39(2):290-8. doi: 10.3109/03639045.2012.679280.

PMID:
22524504
10.

Preparation and evaluation of ketoprofen hot-melt extruded enteric and sustained-release tablets.

Yang R, Wang Y, Zheng X, Meng J, Tang X, Zhang X.

Drug Dev Ind Pharm. 2008 Jan;34(1):83-9. doi: 10.1080/03639040701580572 .

PMID:
18214759
11.

Evaluation of hot-melt extrusion and injection molding for continuous manufacturing of immediate-release tablets.

Melocchi A, Loreti G, Del Curto MD, Maroni A, Gazzaniga A, Zema L.

J Pharm Sci. 2015 Jun;104(6):1971-80. doi: 10.1002/jps.24419.

PMID:
25761921
12.

800 mg Darunavir tablets prepared by hot melt extrusion.

Thommes M, Baert L, Rosier J.

Pharm Dev Technol. 2011 Nov-Dec;16(6):645-50. doi: 10.3109/10837450.2010.508077.

PMID:
20731537
13.

Tableting of coated ketoprofen pellets.

el-Mahdi IM, Deasy PB.

J Microencapsul. 2000 Mar-Apr;17(2):133-44.

PMID:
10738689
14.

Accelerated ketoprofen release from polymeric matrices: importance of the homogeneity/heterogeneity of excipient distribution.

Gue E, Willart JF, Muschert S, Danede F, Delcourt E, Descamps M, Siepmann J.

Int J Pharm. 2013 Nov 30;457(1):298-307. doi: 10.1016/j.ijpharm.2013.09.023.

PMID:
24076398
15.

Development of an osmotic pump system for controlled delivery of diclofenac sodium.

Emara LH, Taha NF, Badr RM, Mursi NM.

Drug Discov Ther. 2012 Oct;6(5):269-77.

16.

Use of highly compressible Ceolus™ microcrystalline cellulose for improved dosage form properties containing a hydrophilic solid dispersion.

Dinunzio JC, Schilling SU, Coney AW, Hughey JR, Kaneko N, McGinity JW.

Drug Dev Ind Pharm. 2012 Feb;38(2):180-9. doi: 10.3109/03639045.2011.595415.

PMID:
21774741
17.

Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.

Schilling SU, Bruce CD, Shah NH, Malick AW, McGinity JW.

Int J Pharm. 2008 Sep 1;361(1-2):158-68. doi: 10.1016/j.ijpharm.2008.05.035.

PMID:
18582547
18.

In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.

Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.

Eur J Pharm Biopharm. 2008 Sep;70(1):302-12. doi: 10.1016/j.ejpb.2008.04.019.

PMID:
18579353
19.

Influence of pressurized carbon dioxide on ketoprofen-incorporated hot-melt extruded low molecular weight hydroxypropylcellulose.

A Ashour E, Kulkarni V, Almutairy B, Park JB, Shah SP, Majumdar S, Lian Z, Pinto E, Bi V, Durig T, Martin ST, Repka MA.

Drug Dev Ind Pharm. 2016 Jan;42(1):123-130.

PMID:
25997363
20.

Effect of core size and excipients on the lag time and drug release from a pulsatile drug delivery system.

Efentakis M, Iliopoyloy A, Siamidi A.

Drug Dev Ind Pharm. 2011 Jan;37(1):113-20. doi: 10.3109/03639045.2010.495753.

PMID:
20615155

Supplemental Content

Support Center